NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $888,925 | +145.4% | 46,250 | +224.6% | 0.00% | +200.0% |
Q2 2023 | $362,235 | -53.4% | 14,250 | -33.7% | 0.00% | -50.0% |
Q1 2023 | $777,225 | +88422.2% | 21,500 | -3.3% | 0.00% | -50.0% |
Q4 2022 | $878 | -100.0% | 22,229 | -59.9% | 0.00% | -63.6% |
Q3 2022 | $2,597,000 | -30.6% | 55,414 | -32.7% | 0.01% | +83.3% |
Q2 2022 | $3,740,000 | +1275.0% | 82,316 | +2209.0% | 0.01% | +500.0% |
Q1 2022 | $272,000 | -94.9% | 3,565 | -94.6% | 0.00% | -92.9% |
Q4 2021 | $5,370,000 | +862.4% | 66,211 | +1549.1% | 0.01% | +1300.0% |
Q1 2021 | $558,000 | -49.3% | 4,015 | -36.8% | 0.00% | -50.0% |
Q4 2020 | $1,100,000 | +39.9% | 6,351 | +12.5% | 0.00% | 0.0% |
Q3 2020 | $786,000 | +16.6% | 5,645 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $674,000 | -83.5% | 5,645 | -86.2% | 0.00% | -88.2% |
Q1 2020 | $4,081,000 | +582.4% | 40,857 | +704.1% | 0.02% | +750.0% |
Q4 2019 | $598,000 | +101.3% | 5,081 | +43.1% | 0.00% | +100.0% |
Q3 2019 | $297,000 | -47.7% | 3,551 | -74.2% | 0.00% | 0.0% |
Q2 2019 | $568,000 | +141.7% | 13,742 | +263.4% | 0.00% | 0.0% |
Q1 2019 | $235,000 | +3816.7% | 3,782 | +2278.6% | 0.00% | – |
Q4 2018 | $6,000 | -98.9% | 159 | -97.0% | 0.00% | -100.0% |
Q3 2016 | $547,000 | +41.0% | 5,300 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $388,000 | – | 5,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |